# Skipping Hormone Therapy in Low-Risk Early Breast Cancer

> **NCT07661927** · PHASE2 · RECRUITING · sponsor: **UNICANCER** · enrollment: 700 (estimated)

## Conditions studied

- Breast Cancer (Early Breast Cancer)

## Interventions

- **DRUG:** Removing Endocrine Therapy

## Key facts

- **NCT ID:** NCT07661927
- **Lead sponsor:** UNICANCER
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-06
- **Primary completion:** 2033-07-06
- **Final completion:** 2033-07-06
- **Target enrollment:** 700 (ESTIMATED)
- **Last updated:** 2026-10-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07661927

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07661927, "Skipping Hormone Therapy in Low-Risk Early Breast Cancer". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07661927. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*